期刊文献+

血清维生素D与高血压靶器官损害的相关研究 被引量:8

Correlational research of vitamin D and end-organ damage in patients with essential hypertension
原文传递
导出
摘要 目的了解血清维生素D在原发性高血压患者不同危险分层的水平变化,分析血清维生素D与原发性高血压合并不同靶器官损害的相关性,并探讨其临床意义。方法选取符合纳入标准的原发性高血压患者118例,按照原发性高血压危险分层标准分为低危组23例,中危组25例,高危组32组,极高危组38例。选取健康体检患者30例作为对照组。采用化学发光法测定每组患者血清维生素D水平,比较各组间差异,并分析维生素D水平与颈动脉内膜中层厚度(IMT)、左心室质量指数(LVMI)的相关性。结果高血压低危组、中危组、高危组、极高危组的血清维生素D水平均低于正常对照组[(27.88±5.34)ng/ml,(23.05±6.74)ng/ml,(19.31±8.08)ng/ml,(17.36±2.66)ng/ml vs.(30.08±4.77)ng/ml,P<0.05],且高血压极高危组、高危组的血清维生素D水平明显低于中危组、低危组(P<0.05)。血清维生素D与IMT、LVMI存在负相关(偏回归系数b值分别为-18.373、-0.021,P<0.10)。结论原发性高血压患者血清维生素D水平降低,尤其是伴有心脏、血管损害的患者维生素D水平降低更明显。维生素D与高血压的发生及发展有一定相关性,可作为高血压病理进展的一个重要预测因子,指导高血压患者的临床诊疗和预后评估。 Objective To observe the serum levels of vitamin D in patients with different risk stratification of essential hypertension, and to explore the relationship between vitamin D level and end-organ damages in the heart, and vessels of patients with essential hypertension. Methods A total of 118 patients diagnosed as essential hypertension were participated in the study. According to the primary hypertension risk stratification standard, all the patients were divided into four groups:low risk group of 23 cases, moderate risk group of 25 cases, high-risk groups of 32 cases and extremely dangerous group of 38 cases, and 30 normal controls enrolled in the study. Serum vitamin D levels of all the cases were evaluated by chemiluminescence method. The differences of serum vitamin D levels between five groups and the correlation between vitamin D levels and carotid intima-media thickness (IMT) and left ventricular mass index (LVMI) were analyzed. Results The concentrations of vitamin D in the four groups of essential hypertension were lower than that in the normal controls [(27.88±5.34)ng/ml, (23.05±6.74)ng/ml, (19.31±8.08)ng/ml, (17.36±2.66)ng/ml vs. (30.08±4.77)ng/ml, P〈0.05], and the vitamin D levels in the extremely dangerous group and the high-risk group were obviously lower than that in low risk group and moderate risk group. Serum vitamin D levels was negatively related to IMT and LVMI (b=-18.373, b=-0.021, P〈0.10). Conclusion Serum vitamin D levels in patients with essential hypertension reduced, and especially lower then that in the patients with damage to the heart, blood vessel and other end-organ.Vitamin D could be an important forecast factor in the pathological progress of hypertension.
出处 《中华临床医师杂志(电子版)》 CAS 2014年第18期53-57,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 山西省科技攻关项目(20120313018-8)
关键词 高血压 维生素D 肥大 左心室 动脉粥样硬化 Hypertension Vitamin D Hypertrophy, leR ventricular Atherosclerosis
  • 相关文献

参考文献14

  • 1Zittetmann A,Gummert JF.Sun,vitamin D,and cardiovascular disease[J].J Photochem Photobiology B,2010,101(2):124-129.
  • 2Kuloglu O.Serum 25-hydroxyvitamin D level is associated with arterial stiffness,left ventricle hypertrophy,and inflammation in newly diagnosed hypertension[J].J Investig Med,2013,61(6):989-994.
  • 3Jones G.Metabolism and biomarkers of Vitamin D[J].Scand J Clin Lab Invest Suppl,2012,243:7-13.
  • 4Koroshi A,Idrizi A.Renoprotective effects of Vitamin D and renin-angiotensin system[J].Hippokratia,2011,15(4):308-311.
  • 5Ohara I,Tanimoto M,Gohda T,et al.Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D3 in type 2 diabetic nephropathy inKK A(y)/Ta mice[J].Nephron Exp Nephrol,2011,117(4):124-132.
  • 6Gonzalez-Parra E,Rojas-Rivera J,Tu?ón J,et al.Vitamin D receptor activation and cardiovascular disease[J].Nephrol Dial Transplant,2012,27 Suppl 4:iv 17-21.
  • 7Jain R,von Hurst PR,Stonehouse W.Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D[J].Metabolism,2012,61(3):293-301.
  • 8von Hurst PR,Stonehouse W,Coad J.Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised,palcebo-controlled trial[J].Br J Nutr,2010,103(2):549-555.
  • 9秦晓伟,徐新娟,韩璐,雷红.维生素D3对自发性高血压大鼠靶器官炎症的影响[J].中国实验动物学报,2013,21(5):1-4. 被引量:2
  • 10Sun J,Kong J,Duan Y,et al.Increased NF-κB activity in fibroblasts lacking the vitamin D receptor[J].Am J Physiol Endocrinol Metab,2006,291(8):315-322.

二级参考文献31

  • 1付艳,刘凤英,刘秀华,刘力生.葛根素对自发性高血压大鼠脑微循环的影响[J].微循环学杂志,2005,15(2):43-44. 被引量:10
  • 2Higgins JP, Thompson SG, Decks JJ, et al. Measuring inconsistency in meta-analyses. BMJ ,2003,327:557-560.
  • 3Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50: 1088-1101.
  • 4Egger M, Smith GD, Schneider M, et al. Bias in Meta-analysis detected by a simple, graphical test. BMJ, 1997,315:629-634.
  • 5Forerun JP, Giovannucci E, Holmes MD, et al. Plasma 25- hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 2007, 49 : 1063-1069.
  • 6Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med, 2007, 167:1159-1165.
  • 7Forman JP, Curhan GC, Taylor EN, et al. Plasma 25- hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008, 52:828-832.
  • 8Ahnirall J, Vaqueiro M, Barb ML, el al. Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant,2009,25:503-509.
  • 9Kumar J, Muntner P~ Kaskel FJ, et al. Prevalence andassociations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics, 2009, 124:362-370.
  • 10Burgaz A, Byberg L, Rautiainen S,et al. Confirmed hypertension and plasma 25 ( OH ) D concentrations amongst elderly men. J Intern Med, 2010, 269:211-218.

共引文献37

同被引文献109

  • 1龙恩武,卿钦,杨艳.HPLC测定人血清中的25-羟维生素D_3[J].华西药学杂志,2010,25(2):181-182. 被引量:3
  • 2陈悦,周建烈.维生素D缺乏的流行病学研究进展[J].中华临床营养杂志,2009,17(5). 被引量:29
  • 3赵兰江,赵冬,刘静,王薇,吴桂贤,秦兰萍,刘军,刘飒,王文化,曾哲淳.血清尿酸水平和甘油三酯关系的人群研究[J].中华内科杂志,2005,44(9):664-667. 被引量:57
  • 4Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency animportant, common, and easily treatable cardiovascular riskfactor-[J]. J Am Coll Cardiol, 2008, 52(24): 1949-1956.
  • 5Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: asystematic review[J]. Lancet Diabetes Endocrinol, 2014, 2(1): 76-89.
  • 6Wat WZ, Leung JY, Tam S, et al. Prevalence and impact of vitaminD insufficiency in southern Chinese adults[J]. Ann Nutr Metab,2007, 51(1): 59-64.
  • 7Macdonald HM. Contributions of sunlight and diet to vitamin Dstatus[J]. Calcif Tissue Int, 2013, 92(2): 163-176.
  • 8Wu SH, Ho SC, Zhong L. Effects of Vitamin D Supplementation onBlood Pressure[J]. Southern Medical Journal, 2010, 103(8): 729-737.
  • 9Olson ML, Maalouf NM, Oden JD, et al. Vitamin D Deficiency inObese Children and Its Relationship to Glucose Homeostasis[J].Journal of Clinical Endocrinology & Metabolism, 2012, 97(1): 279-285.
  • 10Saedisomeolia A, Taheri E, Djalali M, et al. Association betweenserum level of vitamin D and lipid profiles in type 2 diabetic patientsin Iran[J]. J Diabetes Metab Disord, 2014, 13(1): 7.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部